Modulation of Kv7 potassium channels by a novel opener pyrazolo[1,5‐a]pyrimidin‐7(4H)‐one compound QO‐58
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background and Purpose: Modulation of K v 7/M channel function represents a relatively new strategy to treat neuronal excitability disorders such as epilepsy and neuropathic pain. We designed and synthesized a novel series of pyrazolo[1,5‐a] pyrimidin‐7(4H)‐one compounds, which activate K v 7 channels. Here, we characterized the effects of the lead compound, QO‐58, on K v 7 channels and investigated its mechanism of action. Experimental Approach: A perforated whole‐cell patch technique was used to record K v 7 currents expressed in mammalian cell lines and M‐type currents from rat dorsal root ganglion neurons. The effects of QO‐58 in a rat model of neuropathic pain, chronic constriction injury (CCI) of the sciatic nerve, were also examined. Key Results: QO‐58 increased the current amplitudes, shifted the voltage‐dependent activation curve in a more negative direction and slowed the deactivation of K v 7.2/K v 7.3 currents. QO‐58 activated K v 7.1, K v 7.2, K v 7.4 and K v 7.3/K v 7.5 channels with a more selective effect on K v 7.2 and K v 7.4, but little effect on K v 7.3. The mechanism of QO‐58's activation of K v 7 channels was clearly distinct from that used by retigabine. A chain of amino acids, Val 224 Val 225 Tyr 226, in K v 7.2 was important for QO‐58 activation of this channel. QO‐58 enhanced native neuronal M currents, resulting in depression of evoked action potentials. QO‐58 also elevated the pain threshold of neuropathic pain in the sciatic nerve CCI model. Conclusions and Implications: The results indicate that QO‐58 is a potent modulator of K v 7 channels with a mechanism of action different from those of known K v 7 openers. Hence, QO‐58 shows potential as a treatment for diseases associated with neuronal hyperexcitability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625
Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947 · cited 1×
“The nomenclature of Kv7 potassium channels and other receptors and channels conforms to BJP’s Guide to Receptors and Channels (Alexander et al., 2011).”
BackgroundGuidelines for reporting experiments involving animals: the ARRIVE guidelines
McGrath, J., Drummond, G., McLachlan, E., Kilkenny, C., & Wainwright, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00873.x · Cited by 1,592
Cited by
Etiology and Pharmacology of Neuropathic Pain
Alles, S. R. A., & Smith, P. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014399 · Cited by 395
Chemical modulation of Kv7 potassium channels
Borgini, M., Mondal, P., Liu, R., & Wipf, P. (2021) · RSC Medicinal Chemistry · doi:10.1039/d0md00328j · Cited by 37
Liu, Y., Bian, X., & Wang, K. (2021) · Handbook of Experimental Pharmacology · doi:10.1007/164_2021_458 · Cited by 36
Estacion, M., Liu, S., Cheng, X., Dib-Hajj, S., & Waxman, S. G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1138556 · Cited by 11
Lemke, J., Gollasch, M., Tsvetkov, D., & Schulig, L. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2438226 · Cited by 6
“Especially the activity of QO-58 on K V 7.1 and the higher selectivity on K V 7.4 [98] can help to identify more crucial information about the binding sites, activation mechanisms and subtype selectivity.”
Influential
Metadata
- Authors
- Zhang, F., Mi, Y., Qi, J., Li, J., Si, M., Guan, B., Du, X., An, H., & Zhang, H.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2013-01-24
- Volume
- 168
- Issue
- 4
- Pages
- 1030-1042
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1856660863
- Cited by
- 44
- References
- 4
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modulation of Kv7 potassium channels by a novel opener pyrazolo[1,5‐a]pyrimidin‐7(4H)‐one compound QO‐58. https://app.cochat.ai/papers/10.1111/j.1476-5381.2012.02232.x
- The paper
- Zhang, F., Mi, Y., Qi, J., Li, J., Si, M., Guan, B., Du, X., An, H., & Zhang, H. (2013). Modulation of Kv7 potassium channels by a novel opener pyrazolo[1,5‐a]pyrimidin‐7(4H)‐one compound QO‐58. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2012.02232.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.